Suchergebnisse - "Research Support, Non-U.S. Gov't"

PubPharm (8.625)

1

A Randomised Phase II Trial to Evaluate the Feasibility of Radiotherapy Dose Escalation, Facilitated by Intensity-Modulated Arc Radiotherapy Techniques, in High-Risk Neuroblastoma

enthalten in: Clinical oncology (Royal College of Radiologists (Great Britain)) | 2024

von Gains, J. | Patel, A. | Chang, Y. | +6

2

Randomized controlled trial of linaclotide in children aged 6-17 years with functional constipation

enthalten in: Journal of pediatric gastroenterology and nutrition | 2024

von Di Lorenzo, C. | Nurko, S. | Hyams, J. | +5

3

Anlotinib plus docetaxel vs. docetaxel alone for advanced non-small-cell lung cancer patients who failed first-line treatment : A multicenter, randomized phase II trial

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2024

von Pu, X. | Xiao, Z. | Li, J. | +17

4

A phase II randomized, double-blind, placebo-controlled study of Nuvastatic (C50SEW505OESA), a standardized rosmarinic acid-rich polymolecular botanical extract formulation to reduce cancer-related fatigue in patients with solid tumors

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2024

von Ng, M. | Majid, A. | Yee, S. | +13

5

CDK4/6-Inhibitors Versus Chemotherapy in Advanced HR+/HER2-Negative Breast Cancer : Results and Correlative Biomarker Analyses of the KENDO Randomized Phase II Trial

enthalten in: The oncologist | 2024

von Schettini, F. | Palleschi, M. | Mannozzi, F. | +12

6

Combined Lanreotide Autogel and Temozolomide Treatment of Progressive Pancreatic and Intestinal Neuroendocrine Tumors : The Phase II SONNET Study

enthalten in: The oncologist | 2024

von Pavel, M. | Lahner, H. | Hörsch, D. | +7

7

177Lu]Lu-PSMA-617 plus enzalutamide in patients with metastatic castration-resistant prostate cancer (ENZA-p) : an open-label, multicentre, randomised, phase 2 trial

enthalten in: The Lancet. Oncology | 2024

von Emmett, L. | Subramaniam, S. | Crumbaker, M. | +37

8

Effect of NFX-179 MEK inhibitor on cutaneous neurofibromas in persons with neurofibromatosis type 1

enthalten in: Science advances | 2024

von Sarin, K. | Bradshaw, M. | O'Mara, C. | +14

9

"It gave me a sense of achievement and a sense of purpose"-a qualitative study of patient experiences of a virtually supervised exercise program for adults with advanced cancer and cachexia

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2024

von Bland, K. | France-Ratcliffe, M. | Krishnasamy, M. | +6

10

A double-blind, placebo-controlled, randomized withdrawal trial of sarilumab for the treatment of glucocorticoid-dependent sarcoidosis

enthalten in: Rheumatology (Oxford, England) | 2024

von Baker, M. | Horomanski, A. | Wang, Y. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[863]